Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)

NCT02427126 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT02427126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02427126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
September 30, 2021
Enrollment
352 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

embolic stroke of undetermined source